Artemis Medicare Services Limited has scheduled its 22nd Annual General Meeting (AGM) for Friday, July 31, 2026, at 3:00 P.M. (IST) through Video Conferencing (VC) and Other Audio Visual Means (OAVM). The Registered Office at Plot No. 14, Sector 20, Dwarka, Delhi – 110 075 is deemed to be the venue. The company reported a strong financial performance for FY26, with the Board recommending a final dividend of Re. 0.45 per equity share for the financial year ended March 31, 2026.

The AGM notice and Annual Report for FY 2025-26 were submitted to the stock exchanges on July 7, 2026, pursuant to Regulation 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The record date for the final dividend has been fixed as July 10, 2026. If approved, the dividend will be paid within 30 days from the date of declaration to eligible shareholders.

Key AGM Agenda Items

The 22nd AGM covers both ordinary and special business. The following table summarises the key resolutions proposed:

The remote e-Voting period commences on Tuesday, July 28, 2026, at 09:00 A.M. (IST) and ends on Thursday, July 30, 2026, at 05:00 P.M. (IST). The cut-off date for determining eligible voters is Friday, July 24, 2026. The last date for the submission of TDS exemption forms is Wednesday, July 15, 2026.

FY 2025-26 Financial Performance

The company delivered a strong financial performance for the financial year ended March 31, 2026. The following table presents the key financial highlights on both standalone and consolidated bases:

On a standalone basis, revenue from operations grew to Rs. 1,06,049.17 Lacs in FY26 from Rs. 91,326.13 Lacs in FY25. EBITDA improved to Rs. 21,503.08 Lacs from Rs. 18,275.52 Lacs. Finance costs declined to Rs. 2,694.40 Lacs from Rs. 3,048.26 Lacs, while depreciation and amortisation expenses stood at Rs. 4,632.79 Lacs. On a consolidated basis, revenue from operations rose to Rs. 1,08,124.24 Lacs from Rs. 93,691.67 Lacs, with consolidated EBITDA at Rs. 21,800.58 Lacs versus Rs. 18,477.55 Lacs in the previous year.

Operational Highlights and Expansion Initiatives

During FY 2025-26, the company operated a bed capacity of approximately 700 beds at its Gurugram hospital. Average Occupancy Rate stood at 63.0%, with inpatient volumes of 34,428 patients. Average Revenue per Occupied Bed (ARPOB) increased to Rs. 82,435 from Rs. 76,447 in the previous year. The company operationalised its third tower during the year, augmenting bed capacity. It was also awarded a Platinum Green Building certification, which is expected to facilitate the addition of approximately 250 beds over a period of time, scaling capacity to nearly 1,000 beds at a single location.

Key strategic developments during FY26 include:

• Announcement of a new 110 beds facility in Mauritius under the name "Artemis Cascavelle Hospital"
• Upcoming super-speciality hospital in Raipur, expected to operationalise by FY2027
• Signing of a Memorandum of Understanding for development of a ~650 beds facility under the "VIMHANS ARTEMIS HOSPITAL" brand in South Delhi
• Launch of a comprehensive heart and lung transplant program in collaboration with KIMS Hospitals, Hyderabad
• Introduction of a 5G-enabled ambulance service and expansion into train and air ambulance services
• Launch of a dedicated Geriatric and Longevity Program

Board Changes and Director Appointments

The Board as on March 31, 2026 comprised 10 Directors, including 1 Executive Director, 4 Non-Executive Directors, and 5 Independent Directors. Post the financial year, Mr. Tapan Mitra (DIN: 08445248), aged 71 years, was appointed as an Additional Director in the capacity of Independent Director with effect from May 8, 2026, for a term of 3 consecutive years up to May 7, 2029, subject to member approval at the ensuing AGM. Mr. Tapan Mitra has approximately 40 years of experience in Human Resources across manufacturing companies including Apollo Tyres Ltd., Voltas Ltd., and Ballarpur Industries Ltd. (BILT). Dr. Girdhar Jessaram Gyani (DIN: 05169157), aged 76 years, has been recommended for appointment as an Independent Director for a term of 3 consecutive years with effect from August 1, 2026 to July 31, 2029. Dr. Gyani serves as Director General of the Association of Healthcare Providers (India) and was previously Secretary General of the Quality Council of India from 2003 to 2012.

CSR and Dividend Track Record

The company's CSR obligation for FY 2025-26 was Rs. 150.40 Lacs, and the full amount was spent during the year with no unspent balance. The company has maintained a consistent dividend track record, declaring a final dividend of 45% (Re. 0.45 per share) for each of the last three financial years — FY 2024-25, FY 2023-24, and FY 2022-23. The Board has recommended the same final dividend of Re. 0.45 per equity share for FY 2025-26, subject to shareholder approval at the 22nd AGM.

Artemis Medicare Services Limited filed its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26 on July 7, 2026, in compliance with Regulation 34(2)(f) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The report was submitted by Poonam Makkar, Company Secretary and Compliance Officer, and forms part of the company's Annual Report for FY2025-26. The disclosures are made on a standalone basis, covering the entity's operations at three national facilities, with no international offices.

Corporate Overview and Business Activities

Artemis Medicare Services Limited, incorporated in 2004, operates from its corporate address at Artemis Hospital, Sector-51, Gurugram-122001, Haryana. The company's paid-up capital stands at Rs. 15,83,06,247. The following table summarises the company's primary business activity and its contribution to total turnover:

The company has one holding company (Constructive Finance Private Limited) and one subsidiary (Artemis Cardicare Private Limited, with a 65% shareholding). Neither entity participates in the Business Responsibility initiatives of the listed entity.

Workforce Composition and Employee Benefits

The BRSR provides detailed disclosures on the company's workforce for FY2025-26. The total employee count stands at 399, comprising 291 males (72.93%) and 108 females (27.07%). The total worker count is 1,677, comprising 746 males (44.48%) and 931 females (55.52%). The Board of Directors comprises 10 members, of whom 3 (30.00%) are female. Key Managerial Personnel total 3, of whom 2 (66.67%) are female.

The following table presents employee and worker turnover rates across three financial years:

All permanent employees and workers receive remuneration above the minimum wage. The median remuneration for key categories in FY2025-26 is detailed below:

Gross wages paid to females as a percentage of total wages stood at 41.64% in FY2025-26, compared to 40.82% in FY2024-25. Well-being measures cost incurred as a percentage of total revenue was 0.43% in FY2025-26 and 0.47% in FY2024-25. The Lost Time Injury Frequency Rate (LTIFR) and total recordable work-related injuries for both employees and workers were nil in both FY2025-26 and FY2024-25. No fatalities or high-consequence work-related injuries were reported in either year.

ESG Governance and Policy Framework

The company's ESG governance is overseen by a Business Responsibility and Sustainability Committee. The highest authority responsible for implementation and oversight of Business Responsibility policies is Dr. Devlina Chakravarty, Managing Director. Key policies—including the Business Responsibility and Sustainability Policy, Code of Conduct for Directors and Senior Management, Anti-Bribery Fraud and Corruption Policy, Corporate Social Responsibility Policy, Equal Employment Opportunity Policy, Privacy Policy, Related Party Transactions Policy, and Whistle Blower Policy—have all been approved by the Board and translated into procedures. Performance against policies and compliance with statutory requirements are reviewed annually by the Committee of the Board across all nine NGRBC principles.

The company holds accreditations and certifications mapped to its NGRBC principles, including Joint Commission International (JCI), National Accreditation Board for Hospitals and Healthcare Providers (NABH-H, NABH-BB, NABH-EC, NABH-NE, NABH-ES), National Accreditation Board for Testing and Calibration of Laboratories (NABL), and ISO 27001 (Information Security Management System).

Sustainability Initiatives and Environmental Performance

The company achieved the IGBC Platinum Rating certification during FY2025-26, reflecting its commitment to green building practices and sustainable infrastructure. An Organic Waste Composter (OWC) machine was operationalised for on-site treatment of organic waste. Key sustainability initiatives undertaken include:

• Renewable Energy Adoption: Installation of rooftop solar power systems with capacities of 150 kW and 60 kW; installation of solar water heaters.
• Energy Efficiency & Optimization: Installation of Variable Frequency Drives (VFDs) and heat pumps in HVAC systems; replacement of conventional fans with energy-efficient fans in cooling towers.
• Emission Reduction & Air Quality Management: Installation of Retrofit Emission Control Devices (RECDs) in diesel generators to reduce particulate matter (PM), SOx, and NOx emissions; installation of a new diesel generator (DG) set with improved emission and efficiency standards.
• Water Conservation: Installation of water aerators across facilities; enhancement of rainwater harvesting (RWH) capacity.
• Transition to Cleaner Fuels: Replacement of Liquefied Petroleum Gas (LPG) with Piped Natural Gas (PNG) in kitchen operations.

The following table summarises key energy and environmental metrics for FY2025-26 and FY2024-25:

For FY2026-27, the company has set a target of approximately 30% reduction in Scope 2 emissions through a third-party offsite solar energy plant, to be introduced in a phased manner.

Stakeholder Grievances and Compliance

The company has grievance redressal mechanisms in place for all stakeholder groups. During FY2025-26, 148 customer complaints were filed (nil pending at year-end), compared to 553 in FY2024-25 (nil pending). One shareholder complaint was filed in FY2025-26 (nil pending), with nil in FY2024-25. Community complaints stood at nil in FY2025-26 versus 2 in FY2024-25. No complaints related to sexual harassment, discrimination, child labour, forced labour, or wages were filed in either FY2025-26 or FY2024-25.

A monetary penalty of Rs. 10,00,000 was imposed by the Office of the Collector of Stamps, Government of NCT of Delhi, under NGRBC Principle 1, related to delayed filing of an application for determination of stamp duty. No appeal has been preferred. The company reported compliance with all applicable environmental laws, regulations, and guidelines in India, and received no adverse orders from regulatory authorities related to anti-competitive conduct during the current financial year.

CSR and Community Engagement

The company is a member of several industry associations including ASSOCHAM (National), PHD Chamber of Commerce and Industry (National), Federation of Indian Industry Haryana (State), and others. CSR projects undertaken during FY2025-26 include the Green Belt Initiative, Boondh-Rainwater Conservation (benefiting 7,107 persons, 100% from vulnerable groups), Conservation of Solar Energy (benefiting 2,300 persons, 100% from vulnerable groups), It's a FIGHt bK-Tuberculosis Elimination Programme (benefiting 45,553 persons, 100% from vulnerable groups), and Menstrual Health & Hygiene Management (benefiting 4,000 persons, 100% from vulnerable groups). Procurement directly sourced from MSMEs/small producers stood at 52.02% in FY2025-26 versus 53.17% in FY2024-25, and 97.94% was sourced directly from within India in FY2025-26.